By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel's net takeaway is that while Schwab's asset growth is impressive, its earnings power is sensitive to net interest income and maintaining client growth in a competitive, fee-sensitive space. Key risks include deposit beta, funding-cost sensitivity, and regulatory pressures, while the main opportunity lies in Schwab's capacity to rebalance funding toward higher-yielding assets and fee streams.
Risk: Deposit beta and funding-cost sensitivity in a regime of volatile rates
Opportunity: Schwab’s capacity to rebalance funding toward higher-yielding assets and fee streams
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
The Charles Schwab Corporation (NYSE:SCHW) is one of the top stocks to buy for the long-term. On May 15, TD Cowen reiterated a Buy rating on The Charles Schwab Corporation (NYSE:SCHW) and raised the price target to $109 from $108. The research firm also raised its adjusted earnings per share for 2026 and 2027.
Jonathan Weiss/Shutterstock.com
The new $109 price target represents 15 times TD Cowen’s 2027 earnings estimate compared to the previous 16 times. Additionally, the research firm has touted the company’s higher earnings projections, which appear balanced against the lower valuation multiples.
Charles Schwab Corporation released its Monthly Activity Report, which showed that core net new assets totaled $7.2 billion in April, consistent with prior years. Total client assets were up 27% to $12.61 trillion, as New Brokerage accounts opened remained flat at 437,000. On the other hand, average interest-earning assets were up 3% year over year to $444.6 billion in April and up 2% from March 2026.
The Charles Schwab Corporation (NYSE:SCHW) is a major American financial services company that operates as a brokerage firm, bank, and wealth management provider. It provides everyday investors and institutions with tools to trade, save, and invest in the financial markets.
While we acknowledge the potential of SCHW as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 14 Best 52-Week High Stocks to Invest In According to Short Sellers and 15 Best Micro and Small Cap Stocks to Buy According to Jim Simons’ Renaissance Technologies.
Disclosure: None. Follow Insider Monkey on Google News.
Four leading AI models discuss this article
"Modest April inflows and potential NIM compression from rate cuts outweigh the headline asset growth and analyst upgrade."
The article cites TD Cowen's $109 price target (15x 2027 EPS) and 27% YoY client asset growth to $12.61T as reasons SCHW is a long-term buy. Yet April core net new assets of just $7.2B look modest against that base, while interest-earning assets rose only 3% YoY. The piece undercuts itself by immediately steering readers toward a different AI name instead. Rate-cut scenarios could compress net interest margins faster than asset growth offsets, and the 2026/2027 earnings lifts assume continued market appreciation without testing for fee pressure or competition. No discussion of post-SVB regulatory overhang on Schwab's banking book appears.
Higher 2026-27 EPS estimates already baked into the new target could still support re-rating if net interest income stabilizes and brokerage accounts scale without proportional cost increases.
"SCHW's headline growth masks slowing organic net new asset flows and stagnant retail account openings, making the 15x 2027 multiple less compelling than the article suggests."
SCHW's 27% YoY client asset growth to $12.61T is genuinely impressive, but the article conflates asset appreciation with organic growth—most of that is market gains, not net inflows. Core net new assets of $7.2B monthly is solid but unspectacular (~$86B annualized) against a $12.61T base, implying ~0.7% organic growth. TD Cowen's multiple compression (16x to 15x) while raising 2026-27 EPS suggests they're pricing in margin pressure or slower NNA acceleration. The flat 437K new brokerage accounts is a red flag: retail engagement may be cooling. Interest-earning assets up only 3% YoY despite higher rates is concerning—suggests deposit stagnation or customer rebalancing away from cash.
If rate cuts accelerate in H2 2025, net interest margin compression could crater earnings faster than EPS growth can offset, and SCHW's valuation multiple could re-rate downward despite higher nominal earnings.
"Schwab’s long-term upside is entirely dependent on its ability to improve net interest margins through balance sheet optimization, rather than just raw asset accumulation."
The TD Cowen upgrade to $109 reflects optimism regarding SCHW’s earnings power as the firm pivots away from the liquidity crunch that plagued 2023. With client assets reaching $12.61 trillion, the scale is undeniable. However, the core issue is the bank’s net interest margin (NIM) sensitivity. While the article highlights asset growth, it glosses over the high cost of funding these assets via expensive sweep deposits. If the Fed maintains 'higher for longer' rates, SCHW’s reliance on wholesale funding will continue to compress margins. The valuation at 15x forward earnings is reasonable, but only if the firm successfully rotates its balance sheet toward higher-yielding assets without triggering further client attrition.
The thesis ignores the structural risk that Schwab’s business model is essentially a 'bank-in-disguise' that remains highly vulnerable to deposit beta and a potential yield curve inversion that would crush net interest income.
"SCHW's long-term upside depends on sustaining asset growth and net interest income, but that thesis is vulnerable to rate shifts and slower client inflows which could compress both margins and valuation."
Schwab's setup, per the article, hinges on ongoing asset growth and a supportive rate backdrop: April core net new assets of $7.2B, total client assets at $12.61T, and a $109 target implying roughly 15x 2027 earnings. That framing supports a bullish case on long-term growth. Yet the strongest counterpoint is that Schwab’s earnings power greatly depends on net interest income and the ability to keep net-new-asset momentum in a fiercely competitive, fee-sensitive space; if rates flatten or cut, NII can shrink, and if client growth slows or deposits reprioritize, margins and fee revenues could disappoint. The AI/tariff promo in the piece also distracts from fundamentals. A stall in growth could compress multiple despite a higher target.
The growth story could stall if rate volatility reverses, asset growth decelerates, or funding costs rise faster than expected; in that case, the 2027 earnings multiple may re-rate lower and the stock underperform peers.
"Regulatory capital pressure may accelerate deposit costs beyond rate-driven NIM compression, undermining 2027 earnings assumptions."
Claude's flat 437K new accounts pairs with Grok's post-SVB overhang to reveal a potential structural issue: heightened capital rules could force Schwab to bid aggressively for deposits, pushing funding costs above what rate-cut scenarios alone predict. This dynamic would erode the 2027 EPS lifts embedded in TD Cowen's $109 target faster than organic inflows or asset appreciation can compensate.
"Regulatory cost pressure is symmetric across banks; Schwab's real danger is asymmetric deposit-beta risk if rates decline."
Grok's capital-rule friction point is real, but we're conflating two separate pressures. Post-SVB regulatory tightening affects *all* regional banks similarly—it's not a Schwab-specific moat erosion. The sharper risk: Schwab's deposit beta (cost of retaining deposits as rates fall) could exceed peers' because retail clients have lower switching costs than institutional depositors. That's the structural vulnerability nobody isolated yet.
"Schwab's business model forces a margin-destructive cannibalization of brokerage revenue to fund its bank deposits."
Claude, your focus on deposit beta is vital, but you're missing the 'sweep' trap. Schwab’s reliance on internal bank sweeps creates a structural conflict: they must offer competitive rates to prevent client cash sorting into money market funds, yet doing so kills their net interest margin. This isn't just about switching costs; it is about cannibalizing their own high-margin brokerage revenue to save low-margin bank deposits. The regulatory capital floor forces this expensive, margin-dilutive behavior indefinitely.
"The real risk isn't just the sweep 'trap'—it's that Schwab's funding mix and deposit beta could compress NII beyond what asset growth and fees can offset, especially if rate cuts arrive quickly."
Gemini, your 'sweep trap' framing highlights a real margin risk, but it risks overemphasizing cannibalization without acknowledging Schwab’s capacity to rebalance funding toward higher-yield assets and fee streams. The bigger bear case remains deposit beta and funding-cost sensitivity in a regime of volatile rates; if rate cuts come faster than expected, NII could compress more than anticipated, capping earnings even with growth in assets and accounts.
The panel's net takeaway is that while Schwab's asset growth is impressive, its earnings power is sensitive to net interest income and maintaining client growth in a competitive, fee-sensitive space. Key risks include deposit beta, funding-cost sensitivity, and regulatory pressures, while the main opportunity lies in Schwab's capacity to rebalance funding toward higher-yielding assets and fee streams.
Schwab’s capacity to rebalance funding toward higher-yielding assets and fee streams
Deposit beta and funding-cost sensitivity in a regime of volatile rates